Xofluza (baloxavir marboxil) 40mg tabs
Award Notice Posted
- Solicitation number
- 75A50324F80013
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Genentech Usa, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79723D0219-75A50324F80013 Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- South San Francisco, California 94080, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice is for a contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to GENENTECH USA, INC for the supply of Xofluza (baloxavir marboxil) 40mg tablets. The contract value is $21,999,906.94 and was awarded on September 27, 2024. The contract does not have any set-aside requirements.
Notice text
This requirement is for the supply of Xofluza (baloxavir marboxil) 40mg tablets.
Awarded contract 36F79723D0219 to GENENTECH USA, INC for 21999906.94 on 2024-09-27.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity